Endocrine and metabolic diseases pose unique challenges to the scientific and clinical communities. Patients afflicted with these conditions often face great compromises in their quality of life, and they look to the innovators in biomedical science to offer new, more effective treatments. At Ipsen, we take our responsibility to these patients very seriously, and we recognize that important advances are most likely to result when we share knowledge and resources. By fostering strategic partnerships with leading biopharmaceutical companies, Ipsen has already succeeded in bringing three novel products to market. Today, we continue to pursue partnerships with the scientific and clinical communities to develop promising new therapies that help many patients to live fuller, healthier lives.

At Ipsen, we value partnership. With this in mind, we leverage the scientific knowledge and marketing experience of other biopharmaceutical companies whose goals are closely aligned with our own. By working together, we have succeeded in bringing promising new therapies to the marketplace.